Viridian TherapeuticsVRDN
13F holders, Q1 2026 (March 31)225holders −4
39new positions
48sold out
7famous investors
$19.69avg. 13F price*
At the end of Q1 2026, 225 institutions reported holding Viridian Therapeutics Inc. (VRDN) in their 13F filings, down 4 from Q4 2025. 39 opened new positions and 48 sold out. The largest holders were FMR LLC ($300.8M), BlackRock, Inc. ($153.2M) and Bellevue Group AG ($131.6M). 7 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio) and Ken Fisher (0.0% of Fisher Asset Management's portfolio).
- Company
- Viridian Therapeutics Inc.
- CUSIP
- 92790C104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 39 | $33.9M |
| Exits | 48 | $109.5M |
All 13F filers, Q4 2025 → Q1 2026: 20,949,355 shares bought and 17,316,881 shares sold, net +3,632,474 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 225 holders
| FMR LLC | 0.02% | Add +6.9% | 15,379,377 | $300.8M |
| BlackRock, Inc. | 0.00% | Add +21.8% | 7,831,475 | $153.2M |
| Bellevue Group AG | 3.13% | Add +54.3% | 6,726,144 | $131.6M |
| State Street Corp. | 0.00% | Add +34.8% | 4,672,885 | $91.4M |
| Vanguard Capital Management LLC | 0.00% | — | 4,167,201 | $81.5M |
| Fairmount Funds Management LLC | 5.53% | No change | 3,914,458 | $76.6M |
| Venrock Adviser, LLC | 2.83% | No change | 3,882,709 | $75.9M |
| T. Rowe Price Associates Inc. | 0.01% | Reduce -6.8% | 3,206,035 | $62.7M |
| Paradigm Biocapital Advisors LP | 1.26% | Add +118.2% | 3,148,893 | $61.6M |
| Wellington Management Group LLP | 0.01% | Add +56.2% | 3,078,554 | $60.2M |
| Kynam Capital Management, LP | 2.91% | Add +59.2% | 2,341,652 | $45.8M |
| Geode Capital Management, LLC | 0.00% | Add +17.1% | 2,333,213 | $45.6M |
| Citadel Advisors | 0.03% | Add +241.1% | 2,318,234 | $45.3M |
| Balyasny Asset Management L.P. | 0.09% | Add +359.6% | 2,315,957 | $45.3M |
| Alliancebernstein L.P. | 0.01% | Reduce -1.6% | 1,392,072 | $43.3M |
| Novo Holdings A/S | 3.17% | Reduce -16.0% | 2,000,000 | $39.1M |
| Baker Bros. Advisors LP | 0.22% | No change | 1,971,678 | $38.6M |
| Tang Capital Management LLC | 1.78% | No change | 1,792,626 | $35.1M |
| Fisher Asset Management | 0.01% | Reduce -0.7% | 1,768,295 | $34.6M |
| Vanguard Portfolio Management LLC | 0.00% | — | 1,641,477 | $32.1M |
| Goldman Sachs Group Inc. | 0.00% | Add +25.9% | 1,591,945 | $31.1M |
| Avoro Capital Advisors LLC | 0.29% | No change | 1,500,000 | $29.3M |
| Deep Track Capital, LP | 0.56% | Reduce -44.8% | 1,393,944 | $27.3M |
| D. E. Shaw & Co. | 0.02% | Add +26.2% | 1,262,540 | $24.7M |
| Perceptive Advisors LLC | 0.45% | Reduce -61.5% | 1,170,829 | $22.9M |
| Bank of America Corp. | 0.00% | Add +17.5% | 1,163,615 | $22.8M |
| Deutsche Bank AG | 0.01% | Add +115.2% | 1,032,316 | $20.2M |
| JPMorgan Chase & Co. | 0.00% | Add +4.9% | 1,059,864 | $19.6M |
| Adage Capital Partners Gp, L.L.C. | 0.03% | Add +22.8% | 970,018 | $19.0M |
| Loomis Sayles & Co. L P | 0.02% | Reduce -37.4% | 927,717 | $18.1M |
| First Turn Management, LLC | 1.99% | Add +32.0% | 911,337 | $17.8M |
| Rice Hall James & Associates, LLC | 0.98% | Add +1.6% | 898,611 | $17.6M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +537.4% | 888,298 | $17.4M |
| Morgan Stanley | 0.00% | Reduce -49.9% | 870,162 | $17.0M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -2.8% | 727,937 | $14.2M |
| Eversept Partners, LP | 0.92% | Reduce -60.0% | 713,269 | $14.0M |
| Candriam S.C.A. | 0.07% | Reduce -9.3% | 711,739 | $13.9M |
| MetLife Investment Management, LLC | 0.07% | Add +1510.8% | 708,527 | $13.9M |
| Woodline Partners LP | 0.05% | Reduce -37.2% | 700,929 | $13.7M |
| Northern Trust Corp. | 0.00% | Add +4.3% | 696,999 | $13.6M |
| Federated Hermes, Inc. | 0.02% | Add +60.7% | 668,968 | $13.1M |
| MPM Bioimpact LLC | 0.98% | New | 649,873 | $12.7M |
| Nuveen, LLC | 0.00% | Reduce -18.5% | 604,914 | $11.8M |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 591,225 | $11.6M |
| Algert Global LLC | 0.17% | Add +32.7% | 563,999 | $11.0M |
| Parkman Healthcare Partners LLC | 1.13% | Reduce -29.2% | 557,936 | $10.9M |
| Elmind Capital, LP | 2.97% | Reduce -37.7% | 534,931 | $10.5M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -4.7% | 529,763 | $10.4M |
| ExodusPoint Capital Management, LP | 0.06% | Add +256.4% | 330,390 | $6.5M |
| Point72 Asset Management | 0.01% | Add +27.0% | 322,836 | $6.3M |
| Pictet Asset Management Holding SA | 0.01% | Reduce -66.0% | 314,031 | $6.1M |
| Panagora Asset Management Inc. | 0.02% | Reduce -3.4% | 313,700 | $6.1M |
| UBS Group AG | 0.00% | Add +86.3% | 307,134 | $6.0M |
| ADAR1 Capital Management, LLC | 0.36% | Add +294.3% | 304,422 | $6.0M |
| Davern Capital Partners, LP | 1.62% | Add +15.6% | 302,457 | $5.9M |
| First Trust Advisors LP | 0.00% | Add +151.5% | 301,529 | $5.9M |
| Raymond James Financial Inc. | 0.00% | Reduce -3.5% | 293,308 | $5.4M |
| Voleon Capital Management LP | 0.11% | Reduce -22.0% | 269,742 | $5.3M |
| Marshall Wace, LLP | 0.01% | Reduce -80.4% | 269,587 | $5.3M |
| BNP Paribas Financial Markets | 0.00% | Reduce -48.5% | 266,399 | $5.2M |
| Voya Investment Management LLC | 0.01% | Add +1804.0% | 262,017 | $5.1M |
| XTX Topco Ltd | 0.09% | Add +440.0% | 253,972 | $5.0M |
| Rosalind Advisors, Inc. | 2.01% | Reduce -44.4% | 250,401 | $4.9M |
| Affinity Asset Advisors, LLC | 0.29% | No change | 250,000 | $4.9M |
| Russell Investments Group, Ltd. | 0.00% | Add +21.2% | 234,551 | $4.6M |
| Qube Research & Technologies Ltd | 0.01% | Add +78.5% | 231,270 | $4.5M |
| Bank of New York Mellon Corp | 0.00% | Add +0.3% | 216,525 | $4.2M |
| Propel Bio Management, LLC | 2.58% | Reduce -25.6% | 210,163 | $4.1M |
| Yiheng Capital Management, L.P. | 1.77% | No change | 208,735 | $4.1M |
| Renaissance Technologies | 0.01% | New | 203,100 | $4.0M |
| Victory Capital Management Inc. | 0.00% | Reduce -17.0% | 188,177 | $3.7M |
| Knott David M Jr | 2.11% | Add +24.8% | 181,000 | $3.5M |
| Hennion & Walsh Asset Management, Inc. | 0.12% | Add +3.4% | 174,894 | $3.4M |
| Privium Fund Management B.V. | 0.71% | No change | 173,516 | $3.4M |
| Vivo Capital, LLC | 0.27% | Reduce -83.1% | 166,288 | $3.3M |
| Frontier Capital Management Co. LLC | 0.03% | New | 158,371 | $3.1M |
| SEB Asset Management AB | 0.01% | — | 156,957 | $3.1M |
| Invesco Ltd. | 0.00% | Reduce -16.8% | 152,596 | $3.0M |
| Rafferty Asset Management, LLC | 0.01% | Add +42.3% | 141,977 | $2.8M |
| Millennium Management | 0.00% | Reduce -69.4% | 140,595 | $2.8M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.00% | Add +15554.0% | 140,260 | $2.7M |
| HighVista Strategies LLC | 0.72% | Reduce -64.0% | 134,229 | $2.6M |
| Swiss National Bank | 0.00% | No change | 128,600 | $2.5M |
| KVP Capital Advisors, LP | 1.83% | New | 125,000 | $2.4M |
| Nicholas Investment Partners, LP | 0.20% | Add +85.2% | 124,257 | $2.4M |
| Barclays PLC | 0.00% | Reduce -58.8% | 100,598 | $2.0M |
| Rhumbline Advisers | 0.00% | Add +2.6% | 100,033 | $2.0M |
| Moody Aldrich Partners LLC | 0.34% | Reduce -1.0% | 95,235 | $1.9M |
| Merck & Co., Inc. | 0.52% | No change | 93,414 | $1.8M |
| Wells Fargo & Company | 0.00% | Reduce -36.7% | 93,204 | $1.8M |
| Velan Capital Investment Management LP | 1.12% | Add +5.3% | 91,123 | $1.8M |
| Nomura Asset Management International Inc. | 0.00% | Reduce -44.8% | 85,390 | $1.7M |
| Manufacturers Life Insurance Company, The | 0.00% | Reduce -27.7% | 81,425 | $1.6M |
| California State Teachers Retirement System | 0.00% | Add +28.0% | 81,021 | $1.6M |
| Twinbeech Capital LP | 0.16% | Add +61.3% | 76,884 | $1.5M |
| Principal Financial Group Inc. | 0.00% | Reduce -57.3% | 75,200 | $1.5M |
| J. Safra Sarasin Holding AG | 0.02% | Reduce -17.2% | 73,058 | $1.4M |
| State of Wisconsin Investment Board | 0.00% | Add +3.6% | 70,244 | $1.4M |
| Fideuram - Intesa Sanpaolo Private Banking S.P.A. | 0.05% | Add +10.8% | 69,530 | $1.4M |
| Aquatic Capital Management LLC | 0.04% | Add +179.8% | 68,461 | $1.3M |
"% of holder's portfolio" is VRDN's weight in each manager's 13F, not the share of Viridian Therapeutics Inc. the manager owns.